losartan and betadex

losartan has been researched along with betadex in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agu, RU; Amoako-Tuffour, M; Yeung, PK1
Gao, S; Kim, HT; Kim, SH; Lim, JM; Oh, YB; Park, BH1
Bonomini, HIM; De Sousa, FB; Lopes, JF; Meira, LHR; Soares, GAB1
Braga, ANG; De Paula, WX; Denadai, ÂML; Frezard, F; Pinheiro, SVB; Santos, RAS; Shastri, VP; Sinisterra, RD1
Bu, X; Hao, B; Ma, C; Ma, H; Tian, Y; Wu, J; Zhao, B; Zhu, L1

Other Studies

5 other study(ies) available for losartan and betadex

ArticleYear
Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells.
    Acta pharmaceutica (Zagreb, Croatia), 2009, Volume: 59, Issue:4

    Topics: Administration, Intranasal; beta-Cyclodextrins; Biological Availability; Biological Transport; Cell Line; Glycocholic Acid; Humans; Losartan; Nasal Mucosa; Permeability; Pharmaceutical Vehicles

2009
Caveolae are essential for angiotensin II type 1 receptor-mediated ANP secretion.
    Peptides, 2011, Volume: 32, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Natriuretic Factor; beta-Cyclodextrins; Blood Pressure; Catheterization; Caveolae; Chromatography, High Pressure Liquid; Heart Atria; Infusion Pumps; Losartan; Male; Myocardial Contraction; Myocardium; Organ Culture Techniques; Perfusion; Protein Precursors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1

2011
Thermodynamic compatibility between cyclodextrin supramolecular complexes and surfactant.
    International journal of pharmaceutics, 2018, Jun-10, Volume: 544, Issue:1

    Topics: Antihypertensive Agents; Atenolol; beta-Cyclodextrins; Losartan; Magnetic Resonance Spectroscopy; Sodium Dodecyl Sulfate; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; Thermodynamics

2018
A long-lasting oral preformulation of the angiotensin II AT1 receptor antagonist losartan.
    Drug development and industrial pharmacy, 2018, Volume: 44, Issue:9

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; beta-Cyclodextrins; Blood Pressure; Chemistry, Pharmaceutical; Drug Carriers; Losartan; Male; Polymers; Rats; Rats, Transgenic; Rats, Wistar; Receptor, Angiotensin, Type 1

2018
SERS determination of the antihypertensive drugs prazosin and losartan by using silver nanoparticles coated with β-cyclodextrin.
    Mikrochimica acta, 2019, 11-18, Volume: 186, Issue:12

    Topics: Antihypertensive Agents; beta-Cyclodextrins; Losartan; Metal Nanoparticles; Particle Size; Prazosin; Silver; Spectrum Analysis, Raman; Surface Properties

2019